488 related articles for article (PubMed ID: 23844731)
1. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
Hodonsky C; Wu K; Mundada L; Si MS
Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
[TBL] [Abstract][Full Text] [Related]
2. Induced regeneration--the progress and promise of direct reprogramming for heart repair.
Addis RC; Epstein JA
Nat Med; 2013 Jul; 19(7):829-36. PubMed ID: 23836233
[TBL] [Abstract][Full Text] [Related]
3. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
Yoshida Y; Yamanaka S
Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
[TBL] [Abstract][Full Text] [Related]
4. (Re-)programming of subtype specific cardiomyocytes.
Hausburg F; Jung JJ; Hoch M; Wolfien M; Yavari A; Rimmbach C; David R
Adv Drug Deliv Rev; 2017 Oct; 120():142-167. PubMed ID: 28916499
[TBL] [Abstract][Full Text] [Related]
5. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
6. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
7. Potential Strategies for Cardiac Diseases: Lineage Reprogramming of Somatic Cells into Induced Cardiomyocytes.
Wang M; Ling W; Xiong C; Xie D; Chu X; Li Y; Qiu X; Li Y; Xiao X
Cell Reprogram; 2019 Apr; 21(2):63-77. PubMed ID: 30907633
[TBL] [Abstract][Full Text] [Related]
8. Direct somatic cell reprogramming: treatment of cardiac diseases.
Guo C; Patel K; Qian L
Curr Gene Ther; 2013 Apr; 13(2):133-8. PubMed ID: 23320478
[TBL] [Abstract][Full Text] [Related]
9. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
Budniatzky I; Gepstein L
Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
[TBL] [Abstract][Full Text] [Related]
10. Stem cell therapy for cardiac regeneration: hits and misses.
Padda J; Sequiera GL; Sareen N; Dhingra S
Can J Physiol Pharmacol; 2015 Oct; 93(10):835-41. PubMed ID: 26443930
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in direct cardiac reprogramming.
Srivastava D; Yu P
Curr Opin Genet Dev; 2015 Oct; 34():77-81. PubMed ID: 26454285
[TBL] [Abstract][Full Text] [Related]
12. Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
Isomi M; Sadahiro T; Ieda M
J Cardiol; 2019 Feb; 73(2):97-101. PubMed ID: 30420106
[TBL] [Abstract][Full Text] [Related]
13. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
Freund C; Mummery CL
J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
[TBL] [Abstract][Full Text] [Related]
14. Key Regulators of Cardiovascular Differentiation and Regeneration: Harnessing the Potential of Direct Reprogramming to Treat Heart Failure.
Ieda M
J Card Fail; 2020 Jan; 26(1):80-84. PubMed ID: 31541743
[TBL] [Abstract][Full Text] [Related]
15. Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
Tohyama S; Fukuda K
Circ Res; 2017 May; 120(10):1558-1560. PubMed ID: 28495993
[No Abstract] [Full Text] [Related]
16. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine.
Burridge PW; Sharma A; Wu JC
Annu Rev Genet; 2015; 49():461-84. PubMed ID: 26631515
[TBL] [Abstract][Full Text] [Related]
17. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.
Hartman ME; Dai DF; Laflamme MA
Adv Drug Deliv Rev; 2016 Jan; 96():3-17. PubMed ID: 25980938
[TBL] [Abstract][Full Text] [Related]
18. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
Differentiation; 2020; 112():58-66. PubMed ID: 31954271
[TBL] [Abstract][Full Text] [Related]
19. Partial reprogramming as a therapeutic approach for heart disease: A state-of-the-art review.
Talkhabi M
J Cell Biochem; 2019 Sep; 120(9):14247-14261. PubMed ID: 31081174
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration.
He WJ; Hou Q; Han QW; Han WD; Fu XB
Tissue Eng Part B Rev; 2014 Aug; 20(4):304-13. PubMed ID: 24063625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
